Invention Grant
US08017122B2 Methods of using IL-31 monoclonal antibodies to reduce inflammation
有权
使用IL-31单克隆抗体减少炎症的方法
- Patent Title: Methods of using IL-31 monoclonal antibodies to reduce inflammation
- Patent Title (中): 使用IL-31单克隆抗体减少炎症的方法
-
Application No.: US12420747Application Date: 2009-04-08
-
Publication No.: US08017122B2Publication Date: 2011-09-13
- Inventor: Anthony W. Siadak , Janine Bilsborough , Shirley Rene
- Applicant: Anthony W. Siadak , Janine Bilsborough , Shirley Rene
- Applicant Address: US WA Seattle
- Assignee: ZymoGenetics, Inc.
- Current Assignee: ZymoGenetics, Inc.
- Current Assignee Address: US WA Seattle
- Agent Brian J. Walsh
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention relates to methods of treating pruritic diseases, including but not limited to Contact dermatitis, Atopic Dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic epidermal necrolysis, Cutaneous T cell Lymphoma, Bullous pemphigoid, Alopecia wereata, Vitiligo, Acne Rosacea, Prurigo nodularis, Scleroderma, Herpes simplex virus, or combination thereof by administering IL-31 monoclonal antibodies. The invention further provides the hybridomas that generate the monoclonal antibodies.
Public/Granted literature
- US20090220417A1 METHODS OF USING IL-31 MONOCLONAL ANTIBODIES TO REDUCE INFLAMMATION Public/Granted day:2009-09-03
Information query
